- Search results for 18172-33-3
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "18172-33-3"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T15027-10mg
Description: Cyclopiazonic acid (CPA) is a neurotoxic secondary metabolite (SM) made by A. flavus. Cyclopiazonic acid (CPA) is an endoplasmic reticulum calcium ATPase (Ca2+ATPase, SERCA)nanomolar inhibitor and a potent inducer of cell death in plants. Target: Calcium Channel. Smiles:...
Application: | SERCA inhibitor, mycotoxin |
CAS | 18172-33-3 |
MW: | 336.38 D |
From 83.00€
*
Item number: Cay11326-1
Cyclopiazonic acid is a mycotoxin that has been found in Penicillium and Aspergillus and an inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA, IC50 = 0.6 µM). In vivo, cyclopiazonic acid (11-14 mg/kg) induces ptosis, hypothermia, tremor, and cachexia, as well as induces lethality (LD50 = 13 mg/kg),...
Keywords: | CPA, NSC 117181,... |
Application: | SERCA inhibitor, mycotoxin |
CAS | 18172-33-3 |
MW: | 336.4 D |
From 35.00€
*
Item number: LKT-C9809.5
An inhibitor of the sarco/endoplasmic reticulum calcium pump that has produced hypokinesia, hypothermia, catalepsy, ptosis, and sedation without loss of righting reflex, tremor, gait disturbance, dyspnoea, opisthotonus, atypical convulsion, and prolonged barbiturate-induced sleep in mice.
Keywords: | CPA |
Application: | Calcium pump inhibitor |
CAS | 18172-33-3 |
MW: | 336,39 D |
From 232.00€
*